Literature DB >> 33978933

RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway.

Yan Li1, Juan Wang2, Fang Wang2, Wenyu Chen1, Chengzhen Gao1, Jianhua Wang3.   

Abstract

OBJECTIVE: Cancer stem cells (CSCs) are the main driving force of tumorigenesis, metastasis, recurrence, and drug resistance in epithelial ovarian cancer (EOC). The current study aimed to explore the regulatory effects of ring finger protein 144A (RNF144A), an E3 ubiquitin ligase, in the maintenance of CSC properties and tumor development in EOC.
METHODS: The expressions of RNF144A in EOC tissue samples and cells were examined. The knockdown or overexpression of a target gene was achieved by transfecting EOC cells with short hairpin RNA or adenoviral vectors. A mouse xenograft model was constructed by inoculating nude mice with EOC cells. Co-immunoprecipitation was used to determine the interaction between RNF144A and LIN28B.
RESULTS: Downregulated RNF144A expression was observed in ovarian tumor tissues and EOC cells. Low RNF144A expression was positively associated with poor survival of EOC patients. RNF144A knockdown significantly enhanced sphere formation and upregulated stem cell markers in EOC cells, while RNF144A overexpression prevented EOC cells from acquiring stem cell properties. Also, the upregulation of RNF144A inhibited ovarian tumor growth and aggressiveness in cell culture and mouse xenografts. Further analysis revealed that RNF144A induced LIN28B degradation through ubiquitination in EOC cells. LIN28B upregulation restored the expressions of stem cell pluripotency-associated transcription factors in EOC cells overexpressing RNF144A.
CONCLUSION: Taken together, our findings highlight the therapeutic potential of restoring RNF144A expression and thereby suppressing LIN28B-associated oncogenic signaling for EOC treatment. • Ring finger protein 144A (RNF144A) is downregulated in epithelial ovarian cancer (EOC) tissues and cell lines. • The overexpression of RNF144A prevents EOC cells from acquiring stem cell properties and inhibits ovarian tumor growth. • RNF144A induces LIN28B degradation through ubiquitination in EOC cells. • LIN28B upregulation restores the expressions of stem cell pluripotency-associated transcription factors in EOC cells overexpressing RNF144A.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Aldehyde dehydrogenase; Cancer stem cells; LIN28B; Ovarian cancer; Ring finger protein 144A; Ubiquitination

Mesh:

Substances:

Year:  2021        PMID: 33978933     DOI: 10.1007/s10565-021-09609-w

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.819


  36 in total

1.  An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

Authors:  Dimitrios Iliopoulos; Heather A Hirsch; Kevin Struhl
Journal:  Cell       Date:  2009-10-29       Impact factor: 41.582

2.  The stability and oncogenic function of LIN28A are regulated by USP28.

Authors:  Saba Haq; Soumyadip Das; Dong-Ho Kim; Arun Pandian Chandrasekaran; Seok-Ho Hong; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-12-10       Impact factor: 5.187

3.  Diagnosis and Management of Ovarian Cancer.

Authors:  Chyke A Doubeni; Anna R Doubeni; Allison E Myers
Journal:  Am Fam Physician       Date:  2016-06-01       Impact factor: 3.292

4.  RNF144A, an E3 ubiquitin ligase for DNA-PKcs, promotes apoptosis during DNA damage.

Authors:  Shiuh-Rong Ho; Christina S Mahanic; Yu-Ju Lee; Weei-Chin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

5.  Gene profiling of MTA1 identifies novel gene targets and functions.

Authors:  Krishna Sumanth Ghanta; Da-Qiang Li; Jeyanthy Eswaran; Rakesh Kumar
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

6.  Targeting glioma stem cells through combined BMI1 and EZH2 inhibition.

Authors:  Xun Jin; Leo J Y Kim; Qiulian Wu; Lisa C Wallace; Briana C Prager; Tanwarat Sanvoranart; Ryan C Gimple; Xiuxing Wang; Stephen C Mack; Tyler E Miller; Ping Huang; Claudia L Valentim; Qi-Gang Zhou; Jill S Barnholtz-Sloan; Shideng Bao; Andrew E Sloan; Jeremy N Rich
Journal:  Nat Med       Date:  2017-10-09       Impact factor: 53.440

Review 7.  The LIN28/let-7 Pathway in Cancer.

Authors:  Julien Balzeau; Miriam R Menezes; Siyu Cao; John P Hagan
Journal:  Front Genet       Date:  2017-03-28       Impact factor: 4.599

Review 8.  Cancer stem cells as key drivers of tumour progression.

Authors:  Ain Zubaidah Ayob; Thamil Selvee Ramasamy
Journal:  J Biomed Sci       Date:  2018-03-06       Impact factor: 8.410

Review 9.  Presence and role of stem cells in ovarian cancer.

Authors:  Natasa Kenda Suster; Irma Virant-Klun
Journal:  World J Stem Cells       Date:  2019-07-26       Impact factor: 5.326

10.  The expressions of stem cell markers: Oct4, Nanog, Sox2, nucleostemin, Bmi, Zfx, Tcl1, Tbx3, Dppa4, and Esrrb in bladder, colon, and prostate cancer, and certain cancer cell lines.

Authors:  Sabrieh Amini; Fardin Fathi; Jafar Mobalegi; Heshmatollah Sofimajidpour; Tayyeb Ghadimi
Journal:  Anat Cell Biol       Date:  2014-03-13
View more
  2 in total

Review 1.  Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells.

Authors:  Macarena Quiroga; Andrea Rodríguez-Alonso; Gloria Alfonsín; Juan José Escuder Rodríguez; Sara M Breijo; Venancio Chantada; Angélica Figueroa
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

2.  LIN28B Polymorphisms Confer a Higher Postoperative Recurrence Risk in Reproductive-Age Women with Endometrial Polyps.

Authors:  Mei-Yin Lu; Xiao-Hong Li; Jia-Li Niu; Bin Liu
Journal:  Dis Markers       Date:  2022-02-27       Impact factor: 3.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.